Is Cogent Biosciences (NASDAQ:COGT) In A Good Position To Invest In Growth?

Simply Wall StDec 20 01:15

J.P. Morgan Maintains Cogent Biosciences(COGT.US) With Buy Rating, Raises Target Price to $23

Futu NewsDec 18 20:31 · Ratings

Cogent Biosciences (COGT) Gets a Buy From J.P. Morgan

TipRanksDec 18 20:06 · Ratings

Express News | Cogent Biosciences Inc : JP Morgan Raises Target Price to $23 From $21

BreakingsDec 17 13:17

Cogent Biosciences Price Target Maintained With a $15.00/Share by Needham

Dow JonesDec 11 20:27 · Ratings

Express News | Cogent Biosciences Inc : Needham Cuts to Hold From Buy

BreakingsDec 11 19:33